메뉴 건너뛰기




Volumn 6, Issue 6, 2012, Pages 724-727

A case report: Ulcerative colitis, treatment with an antibody against tumor necrosis factor (infliximab), and subsequent liver necrosis

Author keywords

Hepatic transplantation; Infliximab; ; Liver failure; ; Toxicity;

Indexed keywords

AMINOTRANSFERASE; AZATHIOPRINE; CORTICOSTEROID; GANCICLOVIR; INFLIXIMAB; MESALAZINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OLSALAZINE; SALAZOSULFAPYRIDINE; TACROLIMUS;

EID: 84862222876     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2012.02.004     Document Type: Article
Times cited : (18)

References (15)
  • 1
    • 77956049370 scopus 로고    scopus 로고
    • CORRONA Investigators. Risk of elevated liver enzymes associated with TNF inhibitor utilisation in patients with rheumatoid arthritis
    • Sokolove J., Strand V., Greenberg J.D., Curtis J.R., Kavanaugh A., Kremer J.M., et al. CORRONA Investigators. Risk of elevated liver enzymes associated with TNF inhibitor utilisation in patients with rheumatoid arthritis. Ann Rheum Dis 2010, 69(9):1612-1617.
    • (2010) Ann Rheum Dis , vol.69 , Issue.9 , pp. 1612-1617
    • Sokolove, J.1    Strand, V.2    Greenberg, J.D.3    Curtis, J.R.4    Kavanaugh, A.5    Kremer, J.M.6
  • 2
    • 77955292814 scopus 로고    scopus 로고
    • Austrian Society of Gastroenterology and Hepatology. A decade of infliximab: the Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease
    • Miehsler W., Novacek G., Wenzl H., Vogelsang H., Knoflach P., Kaser A., et al. Austrian Society of Gastroenterology and Hepatology. A decade of infliximab: the Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease. J Crohns Colitis 2010, 4(3):221-256.
    • (2010) J Crohns Colitis , vol.4 , Issue.3 , pp. 221-256
    • Miehsler, W.1    Novacek, G.2    Wenzl, H.3    Vogelsang, H.4    Knoflach, P.5    Kaser, A.6
  • 5
    • 4344614501 scopus 로고    scopus 로고
    • Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis
    • Esteve M., Saro C., González-Huix F., Suarez F., Forn M., Vivier J.M. Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis. Gut 2004, 53(9):1363-1365.
    • (2004) Gut , vol.53 , Issue.9 , pp. 1363-1365
    • Esteve, M.1    Saro, C.2    González-Huix, F.3    Suarez, F.4    Forn, M.5    Vivier, J.M.6
  • 6
    • 0037532694 scopus 로고    scopus 로고
    • Hepatits B reactivation in a chronic hepatitis B surface antigen carrier with rheumatoid arthritis treated with infliximab and low dose methotrexate
    • Ostuni P., Botsios C., Punzi L., Sfriso P., Todesco S. Hepatits B reactivation in a chronic hepatitis B surface antigen carrier with rheumatoid arthritis treated with infliximab and low dose methotrexate. Ann Rheum Dis 2003, 62(7):686-687.
    • (2003) Ann Rheum Dis , vol.62 , Issue.7 , pp. 686-687
    • Ostuni, P.1    Botsios, C.2    Punzi, L.3    Sfriso, P.4    Todesco, S.5
  • 7
    • 0038504830 scopus 로고    scopus 로고
    • Fulminant hepatitis after infliximab in a patient with hepatitis B virus treated for an adult onset Still's disease
    • Michel M., Duvoux C., Hezode C., Cherqui D. Fulminant hepatitis after infliximab in a patient with hepatitis B virus treated for an adult onset Still's disease. J Rheumatol 2003, 30(7):1624-1625.
    • (2003) J Rheumatol , vol.30 , Issue.7 , pp. 1624-1625
    • Michel, M.1    Duvoux, C.2    Hezode, C.3    Cherqui, D.4
  • 8
    • 78650431965 scopus 로고    scopus 로고
    • Autoimmine hepatitis induced by infliximab in a patient with Crohn's disease with no relapse after switching to adalimumab
    • Cravo M., Silva R., Serrano M. Autoimmine hepatitis induced by infliximab in a patient with Crohn's disease with no relapse after switching to adalimumab. BioDrugs 2010, 24(Suppl. 1):25-27.
    • (2010) BioDrugs , vol.24 , Issue.SUPPL. 1 , pp. 25-27
    • Cravo, M.1    Silva, R.2    Serrano, M.3
  • 9
    • 77953542643 scopus 로고    scopus 로고
    • Infliximab-related hepatitis: discussion of a case and review of the literature
    • Mancini S., Amorotti E., Vecchio S., Ponz de Leon M., Roncucci L. Infliximab-related hepatitis: discussion of a case and review of the literature. Intern Emerg Med 2010, 5(3):193-200.
    • (2010) Intern Emerg Med , vol.5 , Issue.3 , pp. 193-200
    • Mancini, S.1    Amorotti, E.2    Vecchio, S.3    Ponz de Leon, M.4    Roncucci, L.5
  • 10
    • 77957017374 scopus 로고    scopus 로고
    • Infliximab-induced acute hepatitis during Crohn's disease therapy: absence of cross-toxicity with adalimumab
    • Haennig A., Bonnet D., Thebault S., Alric L. Infliximab-induced acute hepatitis during Crohn's disease therapy: absence of cross-toxicity with adalimumab. Gastroenterol Clin Biol 2010, 34(8-9):e7-e8.
    • (2010) Gastroenterol Clin Biol , vol.34 , Issue.8-9
    • Haennig, A.1    Bonnet, D.2    Thebault, S.3    Alric, L.4
  • 11
    • 67849084977 scopus 로고    scopus 로고
    • Toxic hepatitis induced by infliximab in a patient with rheumatoid arthritis with no relapse after switching to etanercept
    • Carlsen K.M., Riis L., Madsen O.R. Toxic hepatitis induced by infliximab in a patient with rheumatoid arthritis with no relapse after switching to etanercept. Clin Rheumatol 2009, 28(8):1001-1003.
    • (2009) Clin Rheumatol , vol.28 , Issue.8 , pp. 1001-1003
    • Carlsen, K.M.1    Riis, L.2    Madsen, O.R.3
  • 12
    • 0022457904 scopus 로고
    • Hepatotoxicity after treatment with sulfasalazine
    • 197-198.
    • Haines J.D. Hepatotoxicity after treatment with sulfasalazine. Postgrad Med 1986, 79(6):193-194. 197-198.
    • (1986) Postgrad Med , vol.79 , Issue.6 , pp. 193-194
    • Haines, J.D.1
  • 13
    • 0033145613 scopus 로고    scopus 로고
    • Fulminant hepatitis in two children treated with sulfasalazine for Crohn disease
    • Besnard M., Debray D., Durand P., Fabre M., Chardot C., Cézard J.P. Fulminant hepatitis in two children treated with sulfasalazine for Crohn disease. Arch Pediatr 1999, 6(6):643-646.
    • (1999) Arch Pediatr , vol.6 , Issue.6 , pp. 643-646
    • Besnard, M.1    Debray, D.2    Durand, P.3    Fabre, M.4    Chardot, C.5    Cézard, J.P.6
  • 14
    • 0036786888 scopus 로고    scopus 로고
    • Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines
    • Ransford R.A., Langman M.J. Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines. Gut 2002, 51(4):536-539.
    • (2002) Gut , vol.51 , Issue.4 , pp. 536-539
    • Ransford, R.A.1    Langman, M.J.2
  • 15
    • 0026460940 scopus 로고
    • Hypersensitivity with hepatotoxicity to mesalazine after hypersensitivity to sulfasalazine
    • Hautekeete M.L., Bourgeois N., Potvin P., Duville L., Reynaert H., Devis G., et al. Hypersensitivity with hepatotoxicity to mesalazine after hypersensitivity to sulfasalazine. Gastroenterology 1992, 103(6):1925-1927.
    • (1992) Gastroenterology , vol.103 , Issue.6 , pp. 1925-1927
    • Hautekeete, M.L.1    Bourgeois, N.2    Potvin, P.3    Duville, L.4    Reynaert, H.5    Devis, G.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.